Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Waldenstrom Macroglobulinemia 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, T-Cell, Peripheral 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Graft vs Host Disease 1Carcinoma, Renal Cell 1

Interventions

fludarabine phosphate 7Mycophenolic Acid 6Peripheral Blood Stem Cell Transplantation 5Cyclosporine 5Whole-Body Irradiation 4Cyclophosphamide 3Antilymphocyte Serum 3Tacrolimus 2Sunitinib 2Specimen Handling 2Methotrexate 2Busulfan 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1thymoglobulin 1temsirolimus 1sapanisertib 1relatlimab 1pertuzumab 1pazopanib 1palbociclib 1osimertinib 1orantinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1defactinib 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Pentostatin × Plasma cell × Clear all
NCT00698685 2017-03-31

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

University of Arizona

Phase 2 Terminated
14 enrolled 7 charts
GenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Carcinoma, Renal Cell, Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡